BI vs FISCHER: Stock Comparison

Bilcare Ltd vs Fischer Medical Ventures Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Fischer Medical Ventures Limited is the larger company by market capitalisation. Fischer Medical Ventures Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bilcare Ltd and Fischer Medical Ventures Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BI is more favourable on 2 of 11 scored metrics and FISCHER on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FISCHER is the larger company
₹2,486 Cr vs ₹140 Cr
EPS
BI has higher earnings per share
₹0.73 vs ₹0.45
Dividend Yield
FISCHER has a higher dividend yield
0.01% vs 0%
Revenue Growth (TTM YoY)
FISCHER has faster revenue growth
98.7% vs 0%
Qtr Sales Growth
FISCHER has stronger quarterly sales growth
98.8% vs -3.28%
Qtr Profit Growth
BI has stronger quarterly profit growth
301% vs -642%
ROE
FISCHER has a higher ROE
8.59% vs 1.66%
ROCE
FISCHER has a higher ROCE
11.4% vs 5.56%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBIFISCHER
SectorHealthcare
IndustryMedical Equipment & Supplies

Price

MetricBIFISCHER
Live Price₹59.27₹37.94
Day Change-3.64%-2.79%
Volume3,99021.83 L
52-Week High₹75₹1,194.4
52-Week Low₹51.62₹31.05
Distance from 52W High-20.97%-96.82%

Valuation

MetricBIFISCHER
Market Cap₹140 Cr₹2,486 Cr
P/E Ratio80.98x
P/B Ratio6.48x
EPS₹0.73₹0.45
Book Value₹83.6₹5.96
Dividend Yield0%0.01%

Growth

MetricBIFISCHER
Revenue Growth (TTM YoY)0%98.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-3.28%98.8%
Qtr Profit Growth301%-642%

Profitability & Leverage

MetricBIFISCHER
ROE1.66%8.59%
ROCE5.56%11.4%
Net Margin-2.36%6.79%
Operating Margin6.06%14%
Debt to Equity3.15x0.28x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricBIFISCHER
Promoter Holding30.01%11.46% 0.82 pp
FII Holding0.04%4.97% 0.12 pp
DII Holding0%1.38% 0.02 pp
Public Holding69.94%31.5% 0.49 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bilcare Ltd and Fischer Medical Ventures Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.